Farmak discovers and delivers innovative medicines and solutions that enhance people’s lives.
Since the founding of our company, we have been developing innovative solutions for a wide range of chronic and life threatening health conditions that continue to revolutionise healthcare.
We continually expand our market presence in well-regulated and emerging markets by developing and producing high-quality products and maintaining a robust business reputation.
Farmak International is the global business arm of Farmak Group, headquartered in Switzerland. The company focuses on international partnerships, portfolio expansion, and the supply of complex generics and hospital medicines across global markets.
Farmak International works with partners in Europe, the Middle East, Africa, Asia-Pacific, and Latin America. Using this global network, the company helps provide medicines and supports partners in over 60 countries.
Farmak International’s portfolio spans 14 therapeutic areas, including anesthesiology, cardiology, endocrinology, neurology, oncology, immunology, and diagnostic agents. Key focus areas include complex generics, anesthesiology & intensive care, and MRI & CT diagnostics.
The company prioritizes complex generics, hospital medicines, MRI and CT diagnostic agents, and advanced injectable products. Special focus areas also include long-acting injectables, peptides, and drug-device combinations such as pre-filled syringes and autoinjectors.
Farmak Group includes manufacturing, research, and commercial entities across several countries. Key entities include Farmak International AG in Switzerland, Farmak JSC in Ukraine, ICM Farmak S.L.U. in Spain, and commercial offices in the UK, Poland, Czechia, Slovakia, the UAE, and Vietnam.
Farmak International develops and supplies complex generics and hospital medicines across multiple therapeutic areas. The portfolio includes sterile injectables, diagnostic agents, and advanced delivery systems such as pre-filled syringes and autoinjectors.
Complex generics are medicines that require advanced formulation, manufacturing technologies, or specialized delivery systems. These products often involve injectables, long-acting formulations, or drug-device combinations that require significant development expertise.
No. Farmak International does not sell medicines directly to patients. The company supplies pharmaceutical products to distributors, pharmaceutical companies, and healthcare procurement organizations serving hospitals and healthcare systems.
Farmak Group operates EU GMP-certified manufacturing facilities in Ukraine and Spain. The Spanish site focuses on sterile injectable medicines, while the Ukrainian facilities support multiple dosage forms and API production.
Yes. Farmak Group’s manufacturing facilities operate in accordance with EU GMP standards and undergo inspections by international regulatory authorities. Certain products are also certified for markets regulated by authorities such as the MHRA.
Quality and regulatory compliance are ensured through EU GMP manufacturing, comprehensive quality management systems, and regular inspections by international regulatory authorities. Farmak Group’s facilities also operate under internationally recognized certifications and standards supporting global product registrations.
Farmak Group supports supply reliability through diversified manufacturing capabilities, long-term sourcing strategies, and coordinated production planning across its facilities, ensuring stable product availability for partners.
Companies interested in distribution or partnership opportunities can benefit from collaboration through shared market intelligence, portfolio expansion, and tailored support from Farmak International’s Business Development team. Please send your inquiry to bd@farmak.ch to discuss how a partnership can support your company’s growth.
Yes. Farmak International actively explores both in-licensing and out-licensing opportunities and works with partners to help expand their product range, increase market reach, and access regulatory and technical expertise to accelerate growth in complex generics and hospital medicines across international markets.
Yes. Farmak International provides regulatory documentation and dossier support to partners during product registration and lifecycle management to facilitate approvals in different regulatory environments.
You can find job openings at Farmak International on our Careers page or LinkedIn. Interested people can see the jobs and apply online.
The Farmak International communications team answers media questions at media@farmak.ch.
You can find the latest news and updates in the Press Releases part of our website.
Please check your email inbox for our corporate materials.
Please fill all the fields marked by *